A detailed history of Rhenman & Partners Asset Management Ab transactions in Amgen Inc stock. As of the latest transaction made, Rhenman & Partners Asset Management Ab holds 4,250 shares of AMGN stock, worth $1.34 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
4,250
Previous 4,250 -0.0%
Holding current value
$1.34 Million
Previous $1.21 Million 9.85%
% of portfolio
0.13%
Previous 0.12%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$268.87 - $324.56 $67,217 - $81,140
-250 Reduced 5.56%
4,250 $1.21 Million
Q4 2023

Feb 13, 2024

BUY
$255.7 - $288.46 $1.15 Million - $1.3 Million
4,500 New
4,500 $1.3 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Rhenman & Partners Asset Management Ab Portfolio

Follow Rhenman & Partners Asset Management Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhenman & Partners Asset Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Rhenman & Partners Asset Management Ab with notifications on news.